CircuLite Aims To Transform HF Treatment With Miniature Blood Pump
This article was originally published in The Gray Sheet
Executive Summary
CircuLite, a New Jersey start-up, aims to begin a U.S. clinical trial next year for a new treatment option for chronic heart failure patients
You may also be interested in...
Research In Brief
CircuLite: NIH will grant CircuLite up to $3.7 million in a Fast-Track Phase I-II Small Business Innovation Research Grant to develop a pediatric circulatory assist device based on the same technology as the firm's Synergy Pocket Micro-pump, a small impeller-driven ventricular assist device about the size of a AA battery. Saddle Brook, N.J.-based CircuLite will collaborate with the University of Maryland School of Medicine on the project. CircuLite is currently conducting a European trial of Synergy Pocket Micro-pump (1"The Gray Sheet" Sept. 17, 2007)
Research In Brief
CircuLite: NIH will grant CircuLite up to $3.7 million in a Fast-Track Phase I-II Small Business Innovation Research Grant to develop a pediatric circulatory assist device based on the same technology as the firm's Synergy Pocket Micro-pump, a small impeller-driven ventricular assist device about the size of a AA battery. Saddle Brook, N.J.-based CircuLite will collaborate with the University of Maryland School of Medicine on the project. CircuLite is currently conducting a European trial of Synergy Pocket Micro-pump (1"The Gray Sheet" Sept. 17, 2007)
NIH Group Proposes Ventricular Assist Study For “Less Sick” Patients
The National Heart Lung and Blood Institute and an interdisciplinary team of experts is trying to develop a multi-device clinical trial to test the benefits of ventricular assist devices in patients with advanced, but not end-stage, heart failure